August 25, 2010 08:30 ET

SOHM Announces Corporate Updates Highlighting Generic Pharmaceutical Product Expansion and Record Revenue Growth

Sales Continue to Grow in India's $10 Billion Pharmaceutical Market With Increased Penetration Into Global Emerging Markets

BUENA PARK, CA--(Marketwire - August 25, 2010) -  SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories announced today a corporate update highlighting its global expansion and record revenue growth as a generic drug manufacturer. During the past six months the Company has achieved several important milestones which have positioned SOHM as a leading manufacturer and distributor of generic pharmaceuticals to global emerging markets. These milestones include:

  • Expanding and streamlining SOHM India's licensed centralized manufacturing facility for generic pharmaceutical products. The fully licensed pharmaceutical drug manufacturing facility provides product distribution to African, Latin American, and Southeast Asian target markets and also provides valuable credibility within our core market in India. Product offerings increased to a total of 280 private label generic drugs. 

  • Increased generic drug penetration within targeted emerging pharmaceutical markets in Southeast Asia; specifically in Indonesia, Thailand, the Philippines, and Malaysia. Southeast Asia is the fourth-largest pharmaceutical market in the world and is also the world's fastest-growing pharmaceutical market.

  • Appointed two new distributors in Northern India covering the largest states of India. The domestic pharmaceutical market in India continues to grow and is currently over $10 billion in annual sales. Drug production and distribution capabilities expanded in India and increased production ability to emerging markets in Africa, Latin America, and Southeast Asia. 

  • SOHM has grown internationally from 3 employees this time last year to 42 this year and has surpassed all benchmarks set in 2009.

  • SOHM Reported Record Revenue Increase of 600% For The First Quarter of 2010.

About SOHM, Inc.
SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters are located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia.

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For more information, please contact:
    SOHM, Inc.
    Investor Relations
    (714) 522-6700
    Email Contact